{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:44:51Z","timestamp":1792104291900,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03410-4","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:56:40Z","timestamp":1792101400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombotic and hemorrhagic complications in NPM1-mutated AML: Association with APL-like immunophenotype and impact on early mortality"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8295-9431","authenticated-orcid":false,"given":"Emine Merve","family":"Sava\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale Ayd\u0131n","family":"Kaynar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selin","family":"K\u00fc\u00e7\u00fckyurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer Berna Afacan","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eahika Zeynep","family":"Ak\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merih","family":"K\u0131z\u0131l \u00c7akar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytek","family":"Peker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haktan Ba\u011f\u0131\u015f","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Top\u00e7uo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jale","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asena","family":"Dikyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U\u011fur","family":"Kalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet K\u00fcr\u015fad","family":"G\u00fcne\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"23","key":"3410_CR1","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND et al (2016) Genomic Classification and Prognosis in Acute Myeloid Leukemia. N Engl J Med 374(23):2209\u20132221","journal-title":"N Engl J Med"},{"issue":"10","key":"3410_CR2","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/s41375-022-01666-2","volume":"36","author":"R Ranieri","year":"2022","unstructured":"Ranieri R, Pianigiani G, Sciabolacci S, Perriello VM, Marra A, Cardinali V et al (2022) Current status and future perspectives in targeted therapy of NPM1-mutated AML. Leukemia 36(10):2351\u20132367","journal-title":"Leukemia"},{"issue":"12","key":"3410_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H et al (2022) Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140(12):1345\u20131377","journal-title":"Blood"},{"issue":"6","key":"3410_CR4","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1182\/bloodadvances.2024013304","volume":"9","author":"L Ruhnke","year":"2025","unstructured":"Ruhnke L, Bill M, Zukunft S, Eckardt JN, Sch\u00e4fer S, Stasik S et al (2025) Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia. Blood Adv 9(6):1392\u20131404","journal-title":"Blood Adv"},{"issue":"2","key":"3410_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41375-025-02851-9","volume":"40","author":"A Hern\u00e1ndez-S\u00e1nchez","year":"2026","unstructured":"Hern\u00e1ndez-S\u00e1nchez A, Villaverde Ramiro \u00c1, Str\u00e4ng E, Turki AT, Ab\u00e1igar M, Versluis J et al (2026) Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study. Leukemia 40(2):418\u2013428","journal-title":"Leukemia"},{"issue":"7","key":"3410_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1182\/blood.2024024310","volume":"144","author":"J Othman","year":"2024","unstructured":"Othman J, Potter N, Ivey A, Tazi Y, Papaemmanuil E, Jovanovic J et al (2024) Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML. Blood 144(7):714\u2013728","journal-title":"Blood"},{"issue":"4","key":"3410_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1182\/blood.2022018582","volume":"141","author":"L Angenendt","year":"2023","unstructured":"Angenendt L, R\u00f6llig C, Montesinos P, Ravandi F, Juliusson G, R\u00e9cher C et al (2023) Revisiting coexisting chromosomal abnormalities in NPM1-mutated AML in light of the revised ELN 2022 classification. Blood 141(4):433\u2013435","journal-title":"Blood"},{"issue":"29","key":"3410_CR8","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1200\/JCO.19.00416","volume":"37","author":"L Angenendt","year":"2019","unstructured":"Angenendt L, R\u00f6llig C, Montesinos P, Mart\u00ednez-Cuadr\u00f3n D, Barragan E, Garc\u00eda R et al (2019) Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts. J Clin Oncol 37(29):2632\u20132642","journal-title":"J Clin Oncol"},{"issue":"9","key":"3410_CR9","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/ajh.26989","volume":"98","author":"B Falini","year":"2023","unstructured":"Falini B (2023) NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions. Am J Hematol 98(9):1452\u20131464","journal-title":"Am J Hematol"},{"issue":"3","key":"3410_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccell.2018.08.005","volume":"34","author":"L Brunetti","year":"2018","unstructured":"Brunetti L, Gundry MC, Sorcini D, Guzman AG, Huang YH, Ramabadran R et al (2018) Mutant NPM1 Maintains the Leukemic State through HOX Expression. Cancer Cell 34(3):499\u2013512e9","journal-title":"Cancer Cell"},{"issue":"4","key":"3410_CR11","doi-asserted-by":"publisher","first-page":"e70307","DOI":"10.1002\/hem3.70307","volume":"10","author":"F Mannelli","year":"2026","unstructured":"Mannelli F, Crupi F, Bencini S, Feuring M, Ciolli G, Piccini M et al (2026) APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications. Hemasphere 10(4):e70307","journal-title":"Hemasphere"},{"key":"3410_CR12","doi-asserted-by":"crossref","unstructured":"Papadopoulou V, Schiavini G, Stalder G, Basset V, Schoumans J, Nabergoj M et al (2024) Characteristics and Prognosis of Acute Promyelocytic Leukemia-like Nucleophosmin-1-Mutated Acute Myeloid Leukemia in a Retrospective Patient Cohort. Biomedicines. 12(10):2282","DOI":"10.3390\/biomedicines12102282"},{"key":"3410_CR13","doi-asserted-by":"crossref","unstructured":"Hermsen J, Hambley B (2023) The Coagulopathy of Acute Promyelocytic Leukemia: An Updated Review of Pathophysiology, Risk Stratification, and Clinical Management. Cancers (Basel). 15(13):3477","DOI":"10.3390\/cancers15133477"},{"key":"3410_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.thromres.2024.02.017","volume":"236","author":"G Paterno","year":"2024","unstructured":"Paterno G, Palmieri R, Tesei C, Nunzi A, Ranucci G, Mallegni F et al (2024) The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia. Thromb Res 236:30\u201336","journal-title":"Thromb Res"},{"issue":"6","key":"3410_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11864-023-01089-w","volume":"24","author":"M Olivi","year":"2023","unstructured":"Olivi M, Di Biase F, Lanzarone G, Arrigo G, Martella F, Apolito V et al (2023) Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges. Curr Treat Options Oncol 24(6):693\u2013710","journal-title":"Curr Treat Options Oncol"},{"issue":"Supplement 1","key":"3410_CR16","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1182\/blood-2023-173574","volume":"142","author":"F Crupi","year":"2023","unstructured":"Crupi F, Ciolli G, Piccini M, Bencini S, Gianfaldoni G, Peruzzi B et al (2023) APL-like Subset within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating with Early-Onset Vascular Complications. Blood 142(Supplement 1):4224","journal-title":"Blood"},{"issue":"22","key":"3410_CR17","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1182\/blood.V114.22.4135.4135","volume":"114","author":"MP Martelli","year":"2009","unstructured":"Martelli MP, Brunetti L, De Carolis L, Agliani E, Berchicci L, Bonifacio E et al (2009) Acute Myeloid Leukemia with Mutated NPM1 Presenting with Life-Threatening, Either Arterial or Venous, Thromboembolism: a Report of 4 Cases. Blood 114(22):4135","journal-title":"Blood"},{"issue":"7","key":"3410_CR18","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"2","key":"3410_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00277-026-06831-6","volume":"105","author":"X Wang","year":"2026","unstructured":"Wang X, Mo W, Chen M, Sui J, Bian R, Yan X (2026) Vascular complications in NPM1-Mutated acute myeloid leukemia: clinical features and prognosis. Ann Hematol 105(2):41","journal-title":"Ann Hematol"},{"issue":"4","key":"3410_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ajh.25018","volume":"93","author":"EF Mason","year":"2018","unstructured":"Mason EF, Kuo FC, Hasserjian RP, Seegmiller AC, Pozdnyakova O (2018) A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1\/2 mutations and improved outcome. Am J Hematol 93(4):504\u2013510","journal-title":"Am J Hematol"},{"issue":"6","key":"3410_CR21","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","volume":"18","author":"ME Figueroa","year":"2010","unstructured":"Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A et al (2010) Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18(6):553\u2013567","journal-title":"Cancer Cell"},{"issue":"2","key":"3410_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/ijlh.14007","volume":"45","author":"S Gajendra","year":"2023","unstructured":"Gajendra S, Gupta R, Thakral D, Gupta SK, Jain G, Bakhshi S et al (2023) CD34 negative HLA-DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3-ITD mutations. Int J Lab Hematol 45(2):221\u2013228","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"3410_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/ijlh.13357","volume":"43","author":"MJ Arana Rosainz","year":"2021","unstructured":"Arana Rosainz MJ, Nguyen N, Wahed A, Lelenwa LC, Aakash N, Schaefer K et al (2021) Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation. Int J Lab Hematol 43(2):218\u2013226","journal-title":"Int J Lab Hematol"},{"key":"3410_CR24","doi-asserted-by":"crossref","unstructured":"Bewersdorf JP, Zeidan AM (2020) Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? Cells. ;9(10)","DOI":"10.3390\/cells9102310"},{"issue":"14","key":"3410_CR25","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2016-02-701094","volume":"128","author":"EJ Libourel","year":"2016","unstructured":"Libourel EJ, Klerk CPW, van Norden Y, de Maat MPM, Kruip MJ, Sonneveld P et al (2016) Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia. Blood 128(14):1854\u20131861","journal-title":"Blood"},{"key":"3410_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40164-015-0018-x","volume":"4","author":"C Dicke","year":"2015","unstructured":"Dicke C, Amirkhosravi A, Spath B, Jim\u00e9nez-Alc\u00e1zar M, Fuchs T, Davila M et al (2015) Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study. Exp Hematol Oncol 4:22","journal-title":"Exp Hematol Oncol"},{"issue":"42","key":"3410_CR27","doi-asserted-by":"publisher","first-page":"e40222","DOI":"10.1097\/MD.0000000000040222","volume":"103","author":"XL Chen","year":"2024","unstructured":"Chen XL, Zeng SS (2024) Acute myeloid leukemia with NPM1, IDH2, and SETD2 mutations mimicking acute promyelocytic leukemia: A case report and literature review. Med (Baltim) 103(42):e40222","journal-title":"Med (Baltim)"},{"issue":"3","key":"3410_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bjh.19494","volume":"205","author":"S Zhao","year":"2024","unstructured":"Zhao S, Wang J, Lou Y, Huang X, Xie W, Yu W et al (2024) Clinical characteristics of acute myeloid leukaemia patients with a large number of azurophilic granules: A single-centre retrospective study. Br J Haematol 205(3):924\u2013931","journal-title":"Br J Haematol"},{"key":"3410_CR29","doi-asserted-by":"crossref","unstructured":"Paterno G, Palmieri R, Forte V, Del Prete V, Gurnari C, Guarnera L et al (2022) Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience. Cancers (Basel). ;14(22):5640","DOI":"10.3390\/cancers14225640"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03410-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03410-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03410-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:56:41Z","timestamp":1792101401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03410-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":29,"alternative-id":["3410"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03410-4","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"15 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}